Variations in Multiple Birth Rates and Impact on Perinatal Outcomes in Europe.

OBJECTIVE: Infants from multiple pregnancies have higher rates of preterm birth, stillbirth and neonatal death and differences in multiple birth rates (MBR) exist between countries. We aimed to describe differences in MBR in Europe and to investigate the impact of these differences on adverse perinatal outcomes at a population level. METHODS: We used national aggregate birth data on multiple pregnancies, maternal age, gestational age (GA), stillbirth and neonatal death collected in the Euro-Peristat project (29 countries in 2010, N = 5 074 643 births). We also used European Society of Human Reproduction and Embryology (ESHRE) data on assisted conception and single embryo transfer (SET). The impact of MBR on outcomes was studied using meta-analysis techniques with random-effects models to derive pooled risk ratios (pRR) overall and for four groups of country defined by their MBR. We computed population attributable risks (PAR) for these groups. RESULTS: In 2010, the average MBR was 16.8 per 1000 women giving birth, ranging from 9.1 (Romania) to 26.5 (Cyprus). Compared to singletons, multiples had a nine-fold increased risk (pRR 9.4, 95% Cl 9.1-9.8) of preterm birth (<37 weeks GA), an almost 12-fold increased risk (pRR 11.7, 95% CI 11.0-12.4) of very preterm birth (<32 weeks GA). Pooled RR were 2.4 (95% Cl 1.5-3.6) for fetal mortality at or after 28 weeks GA and 7.0 (95% Cl 6.1-8.0) for neonatal mortality. PAR of neonatal death and very preterm birth were higher in countries with high MBR compared to low MBR (17.1% (95% CI 13.8-20.2) versus 9.8% (95% Cl 9.6-11.0) for neonatal death and 29.6% (96% CI 28.5-30.6) versus 17.5% (95% CI 15.7-18.3) for very preterm births, respectively). CONCLUSIONS: Wide variations in MBR and their impact on population outcomes imply that efforts by countries to reduce MBR could improve perinatal outcomes, enabling better long-term child health.

Nordic couples' decision-making processes during assisted reproduction treatments.

OBJECTIVE: To study couples' perceptions of their decision-making process during the first three years of infertility treatments. STUDY DESIGN: This study is a part of a larger project studying the decision-making processes of 22 infertile heterosexual couples, recruited from fertility clinics in all five Nordic countries, over a three year period. A descriptive qualitative method was used. MAIN OUTCOME MEASURES: Process of decision-making during assisted reproduction treatments. RESULTS: Seventeen couples had succeeded in becoming parents after approximately three years. Our study suggests that the decision-making process during fertility treatments has three phases: (i) recognizing the decisions to be made, with subcategories; the driving force, mutual project, (ii) gathering knowledge and experience about the options, with subcategories; trust, patient competence, personalized support, and (iii) adapting decisions to possible options, with subcategories; strategic planning, adaption. The core category was "maintaining control in a situation of uncertainty." CONCLUSIONS: Two parallel processes affect couples' decision-making process, one within themselves and their relationship, and the other in their contact with the fertility clinic. Couples struggle to make decisions, trusting clinic personnel for guidance, knowledge, and understanding. Nevertheless, couples expressed disappointment with the clinics' reactions to their requests for shared decision-making.

Access to artificial reproduction technology in the Nordic countries in 2004.

OBJECTIVE: To survey access to Artificial Reproduction Technology (ART) treatments in 2004 with regard to legislation, geographical location, financing and the kind of ART treatments provided in the Nordic countries. DESIGN: Retrospective descriptive survey of practice at ART clinics and legislation. SETTING: Denmark, Finland, Iceland, Norway and Sweden. SAMPLE: Sixty-six ART clinics registered with the Nordic Fertility Society in autumn 2005. METHODS: A questionnaire was sent to all ART clinics and a survey of legislation concerning ART treatments and public statistics was performed. The response rate was 79%. MAIN OUTCOME MEASURES: Access to ART treatments. RESULTS: The differences in legislation among the countries mainly concerns gamete donation. Couples living in larger cities or densely populated areas have best access to ART treatments. With regard to subsidizing of treatment costs, Finland and Denmark seem to be the best of the Nordic countries. CONCLUSIONS: The main differences among the countries concern the legislation, the cost of the treatments and how those are subsidized.